A phase 1 study of GSK2857916 + Standard of Care (SOC) in first line multiple myeloma patients (DREAMM-9)

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507060-39-00

Acronym

209664

Enrollment

Registered

2024-02-26

Start date

2020-03-04

Completion date

Unknown

Last updated

2025-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Myeloma

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Germany, Italy, Poland, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026